Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Cardiovascular Magnetic Resonance In The Oncology Patient

J. Jordan, R. M. Todd, S. Vasu, W. Hundley
Published 2018 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Patients with or receiving potentially cardiotoxic treatment for cancer are susceptible to developing decrements in left ventricular mass, diastolic function, or systolic function. They may also experience valvular heart disease, pericardial disease, or intracardiac masses. Cardiovascular magnetic resonance may be used to assess cardiac anatomy, structure, and function and to characterize myocardial tissue. This combination of features facilitates the diagnosis and management of disease processes in patients with or those who have survived cancer. This report outlines and describes prior research involving cardiovascular magnetic resonance for assessing cardiovascular disease in patients with or previously having received treatment for cancer.
This paper references
Patterns of chemotherapy-associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study
E. Culakova (2014)
Impairment of diastolic function during short-term anthracycline chemotherapy.
Y. Cottin (1995)
Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging.
G. Armstrong (2012)
Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography.
R. G. Schwartz (1987)
Radiation-associated cardiovascular disease.
M. Adams (2003)
Diagnosis of constrictive pericarditis by tagged cine magnetic resonance imaging.
S. Kojima (1999)
A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin.
M. Ewer (1984)
A Prospective Study of Breast Cancer Patients with Abnormal Strain Imaging
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.
W. Hundley (2010)
Assessment of myocardial fibrosis with cardiovascular magnetic resonance.
N. Mewton (2011)
[Anthracycline-induced cardiotoxicity: cardiac MRI after treatment for childhood cancer].
K. Oberholzer (2004)
Takotsubo-Like Syndrome in Cancer Patients Treated With Immune Checkpoint Inhibitors.
S. Edérhy (2018)
Weekly Doxorubicin Increases Coronary Arteriolar Wall and Adventitial Thickness
D. Eckman (2013)
Creatine Kinase-Overexpression Improves Myocardial Energetics, Contractile Dysfunction and Survival in Murine Doxorubicin Cardiotoxicity
Ashish Gupta (2013)
Relation of acute pericardial disease to malignancy.
M. Imazio (2005)
Blood-Brain Barrier Permeability and Gadolinium: Benefits and Potential Pitfalls in Research.
A. Montagne (2016)
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
D. Cardinale (2015)
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Sui Zhang (2012)
Early myocardial strain changes during potentially car - diotoxic chemotherapy may occur as a result of reductions in left ventricular end - diastolic volume
JH Jordan (2017)
Cardiac magnetic resonance imaging in the evaluation of the late effects of anthracyclines among longterm survivors of childhood cancer
K Ylänen (2013)
Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation
H Mahrholdt (2004)
Fulminant Myocarditis with Combination Immune Checkpoint Blockade.
D. Johnson (2016)
Tako-tsubo (stress-induced) cardiomyopathy and cancer.
C. Burgdorf (2010)
CT and MR imaging of pericardial disease.
Z. Wang (2003)
Early myocardial strain changes during potentially cardiotoxic chemotherapy may occur as a result of reductions in left ventricular end-diastolic volume. Circulation 2017;135:2575–7
JH Jordan (2017)
Equilibrium radionuclide ventriculography in the assessment of cardiotoxicity of chemotherapy and chemoradiotherapy in patients with breast cancer.
G. Lapińska (2012)
Value of CMR for the differential diagnosis of cardiac masses.
Pablo Pazos-López (2014)
Coronary risk factors and myocardial perfusion in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA).
L. Wang (2006)
diac energetics , oxygenation , and perfusion during increased workload in patients with type 2 diabetes mellitus
E Levelt (2016)
Coronary risk factors and myocardial perfusion in asymptomatic adults: the Multi-Ethnic Study of
L Wang
Available at: https:// Accessed
Cardiac Magnetic Resonance Imaging for the Assessment of the Myocardium After Doxorubicin-based Chemotherapy
M. Lunning (2015)
Longitudinal assessment of right ventricular structure and function by cardiovascular magnetic resonance in breast cancer patients treated with trastuzumab: a prospective observational study
A. Barthur (2017)
Quantification of Cardiomyocyte Hypertrophy by Cardiac Magnetic Resonance: Implications for Early Cardiac Remodeling
O. Coelho-Filho (2013)
Can mortality of cancer patients with fever and neutropenia be improved?
K. Thursky (2015)
Cardiovascular Health of Patients With Cancer and Cancer Survivors: A Roadmap to the Next Level.
A. Barac (2015)
Cardiovascular magnetic resonance in pericardial diseases
J. Bogaert (2009)
Cardiac amyloidosis: MR imaging findings
GA Krombach (2007)
Early Detection of Doxorubicin Cardiotoxicity Using Gadolinium Enhanced Cardiovascular Magnetic Resonance Imaging
James C. Lightfoot (2010)
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.
Syed S Mahmood (2018)
Effect of aging on myocardial perfusion reserve.
N. Uren (1995)
Infiltrative cardiomyopathy and pericardial disease.
S. Yusuf (2013)
Dietary nitrate supplementation protects against Doxorubicin-induced cardiomyopathy by improving mitochondrial function.
Shu-Guang Zhu (2011)
Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications.
A. Benetos (2002)
Multi-detector row cardiac computed tomography accurately quantifies right and left ventricular size and function compared with cardiac magnetic resonance.
S. Raman (2006)
Early Myocardial Strain Changes During Potentially Cardiotoxic Chemotherapy May Occur as a Result of Reductions in Left Ventricular End-Diastolic Volume: The Need to Interpret Left Ventricular Strain With Volumes.
J. Jordan (2017)
Cardiovascular Toxic Effects of Targeted Cancer Therapies.
J. Moslehi (2016)
Pathophysiology of exercise intolerance in breast cancer survivors with preserved left ventricular ejection fraction.
M. Haykowsky (2016)
Breast cancer treatment-associated cardiovascular toxicity and effects of exercise countermeasures
A. Yu (2016)
Cardiovascular toxicity associated with adjuvant trastuzumab therapy: prevalence, patient characteristics, and risk factors
A. Onitilo (2014)
Pericardial delayed hyperenhancement with CMR imaging in patients with constrictive pericarditis undergoing surgical pericardiectomy: a case series with histopathological correlation.
Andrew O. Zurick (2011)
Cardiac motion tracking using CINE harmonic phase (HARP) magnetic resonance imaging
N. Osman (1999)
Mode of action of topoisomerase II-targeting agents at a specific DNA sequence. Uncoupling the DNA binding, cleavage and religation events.
B. Sørensen (1992)
Predicting the HER2 status of breast cancer from basic histopathology data: an analysis of 1500 breast cancers as part of the HER2000 International Study.
M. Bilous (2003)
Cardiovascular magnetic resonance in myocarditis: A JACC White Paper.
M. Friedrich (2009)
Evaluation of Myocardial Changes During Breast Adenocarcinoma Therapy to Detect Cardiotoxicity Earlier With MRI (EMBRACE-MRI)
The frequency and severity of cardiovascular toxicity from targeted therapy in advanced renal cell carcinoma patients.
P. S. Hall (2013)
Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
J. Plana (2014)
Primary systemic amyloidosis with delayed progression to multiple myeloma
S. Rajkumar (1998)
Peripheral arterial ischemic events in cancer patients
Saurabh Sanon (2011)
Occult Cardiotoxicity in Childhood Cancer Survivors Exposed to Anthracycline Therapy
Olga H. Toro-Salazar (2013)
Assessment for Long-Term Cardiovascular Impairment Associated With Trastuzumab Cardiotoxicity in HER2-Positive Breast Cancer Survivors
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement
J. Moon (2013)
Incidence and impact of light chain associated (AL) amyloidosis on the prognosis of patients with multiple myeloma treated with autologous transplantation.
K. Desikan (1997)
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
R. Nishimura (2014)
Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging-a pilot study.
R. Wassmuth (2001)
Modulation of cardiovascular toxicity in Hodgkin lymphoma: potential role Jordan
AF Yu (2015)
Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort
D. Mulrooney (2009)
Longitudinal Assessment of Concurrent Changes in Left Ventricular Ejection Fraction and Left Ventricular Myocardial Tissue Characteristics After Administration of Cardiotoxic Chemotherapies Using T1-Weighted and T2-Weighted Cardiovascular Magnetic Resonance
J. Jordan (2014)
Evaluation and management of pericardial effusion in patients with neoplastic disease.
B. Maisch (2010)
Early and late changes in markers of aortic stiffness with breast cancer therapy
S. Grover (2015)
Pilot study evaluating the role of cardiac magnetic resonance imaging in monitoring adjuvant trastuzumab therapy for breast cancer
C. Lawley (2012)
Left Ventricular Mass Change After Anthracycline Chemotherapy
J. Jordan (2018)
Prognostic utility of differential tissue characterization of cardiac neoplasm and thrombus via late gadolinium enhancement cardiovascular magnetic resonance among patients with advanced systemic cancer
Angel T Chan (2017)
Magnetic resonance evaluation of cardiac thrombi and masses by T1 and T2 mapping: an observational study
T. Caspar (2016)
Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease.
Brandon C. Drafts (2013)
Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy.
P. Stoodley (2011)
Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable?
N. Bellenger (2000)
Assessment of myocardial viability by cardiovascular magnetic resonance imaging.
H. Mahrholdt (2002)
Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardized Post Processing
J. Schulz-Menger (2013)
Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy.
T. Neilan (2013)
Slowly resolving global myocardial inflammation/oedema in Tako-Tsubo cardiomyopathy: evidence from T2-weighted cardiac MRI
Christopher Neil (2012)
Early incidence of adriamycin treatment on cardiac parameters in the rat.
Y. Cottin (1994)
Automated assessments of circumferential strain from cine CMR correlate with LVEF declines in cancer patients early after receipt of cardio-toxic chemotherapy
M. Jolly (2017)
Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab
Heloisa Sawaya (2012)
Cardiovascular Magnetic Resonance Assessment of Human Myocarditis: A Comparison to Histology and Molecular Pathology
H. Mahrholdt (2004)
[Update on myocarditis].
M. Moonen (2018)
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.
W. Hundley (2010)
Cardiac MRI studies of transient left ventricular apical ballooning syndrome (takotsubo cardiomyopathy): a systematic review.
G. Leurent (2009)
Long-term prognosis of transient left ventricular ballooning syndrome and cancer.
C. Burgdorf (2011)
Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography.
J. Alexander (1979)
Noninvasive imaging of cardiovascular injury related to the treatment of cancer.
Suwat Kongbundansuk (2014)
Anthracycline-Associated T1 Mapping Characteristics Are Elevated Independent of the Presence of Cardiovascular Comorbidities in Cancer Survivors
J. Jordan (2016)
Exercise program for children and adolescents with leukemia and lymphoma during treatment: A comprehensive review
Giulia Zucchetti (2018)
Anthracycline degradation in cardiomyocytes: a journey to oxidative survival.
P. Menna (2010)
Slowly resolving global myocardial inflammation/oedema in tako-tsubo cardiomyopathy: evidence from T2weighted cardiac MRI. Heart 2012;98:1278–84
C Neil (2012)
Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy.
K. Wang (2017)
2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
R. Nishimura (2014)
Normal values for cardiovascular magnetic resonance in adults and children
N. Kawel-Boehm (2015)
Highly favorable physiological responses to concurrent resistance and high-intensity interval training during chemotherapy: the OptiTrain breast cancer trial
S. Mijwel (2018)
Aortic stiffness increases upon receipt of anthracycline chemotherapy.
Narumol Chaosuwannakit (2010)
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload.
L. Anderson (2001)
Cardiac magnetic resonance imaging in the evaluation of the late effects of anthracyclines among long-term survivors of childhood cancer.
Kaisa Ylänen (2013)
ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents
Accf Task Force Members (2010)
Role of three-dimensional echocardiography in breast cancer: comparison with two-dimensional echocardiography, multiple-gated acquisition scans, and cardiac magnetic resonance imaging.
J. Walker (2010)
Lower Mitochondrial Energy Production of the Thigh Muscles in Patients With Low‐Normal Ankle‐Brachial Index
M. AlGhatrif (2017)
Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial
J. Greenwood (2012)
Association of Feature-Tracking Cardiac Magnetic Resonance Imaging Left Ventricular Global Longitudinal Strain With All-Cause Mortality in Patients With Reduced Left Ventricular Ejection Fraction.
S. Romano (2017)
Comparison of the Diagnostic Performance of Four Quantitative Myocardial Perfusion Estimation Methods Used in Cardiac MR Imaging: CE-MARC Substudy.
J. Biglands (2015)
ARC is a critical cardiomyocyte survival switch in doxorubicin cardiotoxicity
Junfeng An (2008)
Myxoma of the mitral valve: diagnosis by 2-dimensional and 3-dimensional echocardiography.
M. Handke (1999)
Fatigability, Exercise Intolerance, and Abnormal Skeletal Muscle Energetics in Heart Failure
K. Weiss (2017)
Cardiotoxicity Profile of Trastuzumab
S. Ewer (2008)
Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide.
M. Feola (2011)
Adriamycin cardiotoxicity and proton nuclear magnetic resonance relaxation properties.
R. Thompson (1987)
Cardiac amyloidosis causing cardiac dysfunction: analysis of 54 necropsy patients.
W. Roberts (1983)
The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy.
N. Fallah-Rad (2011)
KEY WORDS cardio-oncology, cardiovascular magnetic resonance, tissue characterization APPENDIX For supplemental videos, please see the online version of this paper
Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging.
R. McDonald (2015)
Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring
A. Jones (2009)
Macrocyclic and Other Non–Group 1 Gadolinium Contrast Agents Deposit Low Levels of Gadolinium in Brain and Bone Tissue: Preliminary Results From 9 Patients With Normal Renal Function
N. Murata (2016)
Understanding cardiovascular injury after treatment for cancer: an overview of current uses and future directions of cardiovascular magnetic resonance
S. Vasu (2013)
Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy
N. Fallah-Rad (2008)
Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance
N Bellenger (2000)
Anthracycline-induced suppression of GATA-4 transcription factor: implication in the regulation of cardiac myocyte apoptosis.
Y. Kim (2003)
Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio.
A. Childs (2002)
Cardiac amyloidosis: MR imaging findings and T1 quantification, comparison with control subjects
G. Krombach (2007)
Cardiac energetics, oxygenation, and perfusion during increased workload in patients with type 2 diabetes mellitus
E. Levelt (2016)
Nonischemic myocardial changes detected by cardiac magnetic resonance in critical care patients with sepsis.
Yasmin Siddiqui (2013)
Cardiovascular Toxicities Associated with Cancer Immunotherapies
D. Wang (2017)
Cancer and the heart.
R. Dobson (2018)
Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: a retrospective study
D. Wadhwa (2008)
DENSE: displacement encoding with stimulated echoes in cardiac functional MRI.
A. Aletras (1999)
Novel Approach to Early Detection of Doxorubicin Cardiotoxicity by Gadolinium-Enhanced Cardiovascular Magnetic Resonance Imaging in an Experimental Model
James C. Lightfoot (2010)
Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling
E. Tham (2013)
Cerebral Perfusion and Aortic Stiffness Are Independent Predictors of White Matter Brain Atrophy in Type 1 Diabetic Patients Assessed With Magnetic Resonance Imaging
S. V. van Elderen (2011)
1 1 , N O . 8 , 2 0 1 8 and mechanisms of aerobic training
Cognitive Effects of Cancer and Cancer Treatments.
T. Ahles (2018)
Trastuzumab-induced cardiac dysfunction.
G. Panjrath (2007)
Inside myocardial dysfunction in septic shock: mechanism of troponin release highlighted by cardiac magnetic resonance.
M. De Lazzari (2017)
Advances in the understanding of myocarditis.
P. Liu (2001)
of Breast Cancer Patients with Abnormal Strain Imaging
A Prospective Stud (2018)
Long‐term prognosis of the transient left ventricular dysfunction syndrome (Tako‐Tsubo cardiomyopathy): Focus on malignancies
C. Burgdorf (2008)
Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review.
P. Thavendiranathan (2014)
Anthracycline-associated T1 mapping characteris
J H Jordan
Cardiac complications of oncologic therapy.
C. Walker (2013)
Cardiovascular magnetic resonance imaging for diagnosis and clinical management of suspected cardiac masses and tumours.
Sandra Fussen (2011)
Detection of intracardiac masses in patients with coronary artery disease using cardiac magnetic resonance imaging: a comparison with transthoracic echocardiography
W. Staab (2013)
Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab.
J. Hare (2009)
Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy.
P. Thavendiranathan (2013)
Frequency of Left Ventricular End-Diastolic Volume-Mediated Declines in Ejection Fraction in Patients Receiving Potentially Cardiotoxic Cancer Treatment.
Giselle C. Meléndez (2017)
The anti-cancer drug, doxorubicin, causes oxidant stress-induced endothelial dysfunction.
M. B. Wolf (2006)
Anthracyclines cause endothelial injury in pediatric cancer patients: a pilot study.
A. Chow (2006)
Intracardiac Thrombosis and Embolism in Patients With Cardiac Amyloidosis
D. Feng (2007)
ErbB2 overexpression upregulates antioxidant enzymes, reduces basal levels of reactive oxygen species, and protects against doxorubicin cardiotoxicity.
Frances Belmonte (2015)
Modulation of cardiovascular toxicity in Hodgkin lymphoma: potential role and mechanisms of aerobic training.
A. Yu (2015)
Vascular and Metabolic Implications of Novel Targeted Cancer Therapies: Focus on Kinase Inhibitors.
Weijuan Li (2015)
MR evaluation of the pericardium and cardiac malignancies.
C. White (1996)
Progressive 3month increase in left ventricular myocardial extracellular volume fraction after receipt of anthracycline based chemotherapy
GC Meléndez (2016)
diotoxicity after anthracycline chemotherapy in breast carcinoma : effects on left ventricular ejection fraction , troponin I and brain natriuretic peptide
M Feola (2011)
bone tissue: preliminary results from 9 patients with normal renal function
N Murata (2016)
Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines.
T. Neilan (2012)
Anthrazyklin-induzierte Kardiotoxizität: MRT des Herzens bei Kindern und Jugendlichen mit malignen Erkrankungen
K. Oberholzer (2004)

This paper is referenced by
MRI in cardio‐oncology: A review of cardiac complications in oncologic care
Daniel Jeong (2019)
Opções Contemporâneas de Rastreio da Cardiotoxicidade Relacionada a Tratamentos Oncológicos
B. H. paula (2019)
Health care utilization and mortality associated with heart failure‐related admissions among cancer patients
A. Guha (2019)
Cardio-toxicity among patients with sarcoma: a cardio-oncology registry
S. Shamai (2020)
Left ventricular mechanics in patients with hematological malignancies before initiation of chemo- and radiotherapy
Milan Pavlovic (2020)
The Role of Speckle Strain Echocardiography in the Diagnosis of Early Subclinical Cardiac Injury in Cancer Patients—Is There More Than Just Left Ventricle Global Longitudinal Strain?
Michal Laufer-Perl (2021)
MRI of Cardiotoxicity.
J. Jordan (2019)
Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio‐Oncology Council of the European Society of Cardiology (ESC)
J. Celutkiene (2020)
Magnetic Resonance Imaging to Detect Cardiovascular Effects of Cancer Therapy: JACC CardioOncology State-of-the-Art Review
I. Harries (2020)
Precision Cardio-Oncology
Alexandra D Dreyfuss (2019)
The role of exercise in the diagnosis and treatment of long-term and late effects of childhood cancer
Treya M Long (2019)
Does self-reported pregnancy loss identify women at risk of an adverse cardiovascular phenotype in later life? Insights from UK Biobank
E. Elmahi (2019)
Takotsubo syndrome: an overview of pathophysiology, diagnosis and treatment with emphasis on cancer patients
Isabela Bispo Santos da Silva da Costa (2019)
Looking for trouble: Reduced myocardial flow reserve following anthracyclines
M. C. Ziadi (2019)
Differences Between the Pathophysiology of Myocardial Infarction Related Cardiomyopathy and Anthracycline Related Cardiomyopathy
Tjerk Tjerk Scheepstra (2019)
Cardio-Oncology Education and Training: JACC Council Perspectives.
Jose Alvarez-Cardona (2020)
Simultaneous Left Ventricular Volume and Strain Changes During Chemotherapy Associate With 2‐Year Postchemotherapy Measures of Left Ventricular Ejection Fraction
Cynthia K. Suerken (2020)
Subclinical Left Ventricular Dysfunction During Chemotherapy
Martin Nicol (2019)
Cardiovascular care of the oncology patient during COVID-19: An expert consensus document from the ACC Cardio-Oncology and Imaging Councils
Lauren A Baldassarre (2020)
Cardiovascular Imaging Through the Prism of Modern Metrics.
A. Choi (2020)
Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy
Treya M Long (2019)
Remote Ischemic Preconditioning Ameliorates Anthracycline-induced Cardiotoxicity and Preserves Mitochondrial Integrity.
Carlos Galán‐Arriola (2020)
Full Issue PDF
Leslee J. Shaw (2020)
Cancer du sein et cardiotoxicité des traitements : prévenir, dépister et structurer le suivi cardio-gynécologique
Martin Nicol (2020)
Reply: CMR and Tissue Characterization: Don't Forget the Strain!
Carlos Galán‐Arriola (2019)
The Role of Cardiac MRI in Animal Models of Cardiotoxicity: Hopes and Challenges
Carolyn J. Park (2020)
Remote Ischemic Preconditioning Ameliorates Anthracycline-induced Cardiotoxicity and Preserves Mitochondrial Integrity
Carlos Galán‐Arriola (2020)
Serial Mapping for Evaluating Cardiac Therapies: Promising, But Not Perfect.
J. Sanz (2020)
Anthracycline-Induced Cardiotoxicity: Remembering the Forgotten Ventricle
J. Liu (2020)
Cardiovascular toxicity of PI3Kα inhibitors.
Chandu Sadasivan (2020)
Cardiotoxicity in cancer treatment: new frontiers in the multimodality diagnostic approach
J. B. D. A. Filho (2020)
A Pilot Study of Cardiac MRI in Breast Cancer Survivors After Cardiotoxic Chemotherapy and Three-Dimensional Conformal Radiotherapy
C. Bergom (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar